Finance
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
This comes just a week after news broke that Bright Health plans IPO.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.
The funds will be used to develop the firm’s non-invasive blood sensing technology.
WELL Health plans on keeping Intrahealth a stand-alone business in its EMR group.
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
The deal is valued at about $194 million and will drive about a third of the telemedicine company's expected revenue moving forward.
IBH will now have access to Uprise's mental healthcare services, which include self-guided modules and coaching.
Since January 2021, all 72 million statutorily insured German citizens have been legally entitled to a national electronic patient record (ePA).
In Q4 Amwell reported $60.4 million in revenue up 34% from Q4 2019.